首页> 美国卫生研究院文献>Chemical Science >Strategies based on metal-based nanoparticles for hypoxic-tumor radiotherapy
【2h】

Strategies based on metal-based nanoparticles for hypoxic-tumor radiotherapy

机译:基于金属纳米粒子的缺氧肿瘤放疗策略

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Radiotherapy (RT) is one of the most effective and frequent clinical cancer treatments. Nevertheless, RT can cause damage to normal tissues around tumors under high-dose ionizing radiation. Inspired by versatile metal-based nanomaterials, great efforts have been devoted to developing nanomaterials with high-Z metal elements as radiosensitizers by depositing more energy into tumors for RT enhancement. However, these metal-based nanomaterial-mediated RTs are highly O2-dependent. Unfortunately, O2 concentrations within the majority of solid tumors exhibit low levels, which seriously hampers the antitumor efficacy of these nanomaterials during RT. Therefore, the development of novel metal-based nanomaterials as radiosensitizers capable of avoiding the radioresistance induced by tumor hypoxia is highly desirable and important. Currently, the most effective approaches to reverse the radioresistance of hypoxic tumors are to introduce nanomaterials with O2-elevating ability by delivering exogenous O2, generating O2in situ, increasing intratumoral blood flow, or reducing HIF-1 expression to harness the O2 level in solid tumors. Besides these, recently, some innovative and simple strategies by employing nanoradiosensitizers with diminished oxygen dependence have also been applied to combat unmet hypoxic challenges, in which nanoradiosensitizers can target tumor hypoxia for selective RT, enhance oxygen-independent ROS generation, or combine with non-oxygen dependent cancer therapies for synergistic treatments. These approaches and strategies provide new avenues for enhanced hypoxic-tumor RT. Nevertheless, an overall review aiming specifically at these strategies is still rare. Herein, we present an overview about recent advances in metal-based nanomaterials for hypoxic-tumor RT, and give a detailed discussion about the design and working mechanisms of these strategies in their application of RT. Finally, current challenges and future perspectives are also pointed out in this field.
机译:放射疗法(RT)是最有效,最常见的临床癌症治疗方法之一。然而,在大剂量电离辐射下,RT可能会损坏肿瘤周围的正常组织。受通用金属基纳米材料的启发,人们通过将更多的能量沉积到肿瘤中以增强RT,致力于开发具有高Z金属元素作为放射增敏剂的纳米材料。但是,这些基于金属的纳米材料介导的RT高度依赖于O2。不幸的是,大多数实体瘤中的O2浓度低,严重阻碍了这些纳米材料在RT期间的抗肿瘤功效。因此,迫切需要开发重要的新型金属基纳米材料作为放射增敏剂,其能够避免由肿瘤缺氧引起的抗辐射性。当前,逆转缺氧肿瘤放射线抵抗的最有效方法是通过递送外源O2,原位产生O2,增加瘤内血流量或降低HIF-1表达以利用实体​​瘤中O2的水平来引入具有O2升高能力的纳米材料。 。除此之外,最近还采用了一些创新的,简单的策略,即通过使用氧依赖性降低的纳米放射增敏剂来应对未满足的缺氧挑战,其中纳米放射增敏剂可以针对肿瘤缺氧进行选择性RT,增强氧非依赖性ROS生成或与非氧联用。用于协同治疗的氧依赖性癌症疗法。这些方法和策略提供了增强缺氧肿瘤放疗的新途径。尽管如此,针对这些策略的全面评估仍然很少。在本文中,我们概述了用于低氧肿瘤RT的金属基纳米材料的最新进展,并对这些策略在RT应用中的设计和工作机理进行了详细讨论。最后,该领域还指出了当前的挑战和未来的前景。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号